Milestone Pharmaceuticals is trading 5.2% lower at $0.75 in after-hours trading, with no verified company-specific announcement explaining the decline.
- It closed at $0.79 on October 29, 2026, after three consecutive higher closes.
- Its latest located press release, dated October 19, announced upcoming cardiology-conference presentations; its releases page shows no October 29 announcement.
- Nasdaq compliance concerns appeared in search results, but available evidence does not establish them as the cause of this after-hours move.